DK54791A - Anti-androgenforbindelser - Google Patents

Anti-androgenforbindelser Download PDF

Info

Publication number
DK54791A
DK54791A DK054791A DK54791A DK54791A DK 54791 A DK54791 A DK 54791A DK 054791 A DK054791 A DK 054791A DK 54791 A DK54791 A DK 54791A DK 54791 A DK54791 A DK 54791A
Authority
DK
Denmark
Prior art keywords
androgen compounds
androgen
compounds
Prior art date
Application number
DK054791A
Other languages
English (en)
Other versions
DK54791D0 (da
DK173840B1 (da
Inventor
Shutsung Liao
John Pataki
Ronald G Harvey
Original Assignee
Arch Dev Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1989/004312 external-priority patent/WO1990003979A2/en
Application filed by Arch Dev Corp filed Critical Arch Dev Corp
Publication of DK54791D0 publication Critical patent/DK54791D0/da
Publication of DK54791A publication Critical patent/DK54791A/da
Application granted granted Critical
Publication of DK173840B1 publication Critical patent/DK173840B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/17Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings containing other rings in addition to the six-membered aromatic rings, e.g. cyclohexylphenol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/513Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/516Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of nitrogen-containing compounds to >C = O groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/657Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/657Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
    • C07C49/665Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/782Ketones containing a keto group bound to a six-membered aromatic ring polycyclic
    • C07C49/792Ketones containing a keto group bound to a six-membered aromatic ring polycyclic containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0055Estrane derivatives not substituted in position 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0059Estrane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • C07J1/0088Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK199100547A 1988-09-30 1991-03-26 Substitueret phenanthrenforbindelse, farmaceutisk præparat med anti-androgen virkning indeholdende en sådan forbindelse, anvendelse af forbindelsen til fremstiling af dette farmaceutiske præparat samt fremgangsmåde til lokalisering af DK173840B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US25237588A 1988-09-30 1988-09-30
US25237588 1988-09-30
US07/413,249 US5208263A (en) 1988-09-30 1989-09-27 Anti-androgen compounds
US41324989 1989-09-27
US8904312 1989-10-02
PCT/US1989/004312 WO1990003979A2 (en) 1988-09-30 1989-10-02 Anti-androgen compounds

Publications (3)

Publication Number Publication Date
DK54791D0 DK54791D0 (da) 1991-03-26
DK54791A true DK54791A (da) 1991-05-22
DK173840B1 DK173840B1 (da) 2001-12-10

Family

ID=26942275

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199100547A DK173840B1 (da) 1988-09-30 1991-03-26 Substitueret phenanthrenforbindelse, farmaceutisk præparat med anti-androgen virkning indeholdende en sådan forbindelse, anvendelse af forbindelsen til fremstiling af dette farmaceutiske præparat samt fremgangsmåde til lokalisering af

Country Status (7)

Country Link
US (1) US5208263A (da)
EP (1) EP0363128B1 (da)
JP (1) JP2959785B2 (da)
CA (1) CA1338667C (da)
DE (1) DE68908829T2 (da)
DK (1) DK173840B1 (da)
ES (1) ES2059779T3 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5480913A (en) * 1989-09-27 1996-01-02 Arch Development Corporation Anti-androgen compounds
US6696459B1 (en) * 1994-12-22 2004-02-24 Ligand Pharmaceuticals Inc. Steroid receptor modulator compounds and methods
US5696127A (en) 1994-12-22 1997-12-09 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
US6699714B1 (en) 1998-07-17 2004-03-02 University Of Rochester Androgen receptor coactivators
PT1955700E (pt) * 1999-09-30 2011-05-04 Harbor Biosciences Inc Tratamento terap?utico de doen?as associadas ao receptor de androg?nios
WO2002082081A2 (en) * 2001-04-06 2002-10-17 University Of Rochester Suppression of androgen receptor transactivation through new pathways to ar and ar coactivators and repressors
CN103435462B (zh) * 2013-07-10 2015-03-11 安徽师范大学 一种茚幷菲酮衍生物及其制备方法
WO2019228794A1 (en) * 2018-05-31 2019-12-05 Societe Des Produits Nestle S.A. Direct ampk activator compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1326731A (fr) * 1962-05-14 1963-05-10 Hoffmann La Roche Procédé pour la préparation de dérivés de polyhydrophénanthrènes
GB1119068A (en) * 1964-09-17 1968-07-03 Shionogi & Co Improvements in or relating to phenanthrene compounds and their preparation
FR6828M (da) * 1966-11-10 1969-03-31
US3992437A (en) * 1973-08-31 1976-11-16 Sterling Drug Inc. Polyhydrophenanthrene derivatives
US4034045A (en) * 1975-04-10 1977-07-05 Sandoz, Inc. 2,4-Disubstituted-4b,5,6,7,8,8a,9,10-octahydro-9-oxo-phenanthrenes

Also Published As

Publication number Publication date
EP0363128B1 (en) 1993-09-01
DK54791D0 (da) 1991-03-26
JP2959785B2 (ja) 1999-10-06
DE68908829T2 (de) 1994-01-05
DK173840B1 (da) 2001-12-10
ES2059779T3 (es) 1994-11-16
EP0363128A3 (en) 1990-10-10
DE68908829D1 (de) 1993-10-07
EP0363128A2 (en) 1990-04-11
CA1338667C (en) 1996-10-22
JPH04501409A (ja) 1992-03-12
US5208263A (en) 1993-05-04

Similar Documents

Publication Publication Date Title
FI895936A7 (fi) Yhdisteitä
DK55889D0 (da) Substituerede pyrroler
DK103389A (da) Forbedret braender
DE3751890D1 (de) Radionuklid-Antikörper-Verbindung
DK85993A (da) 2-anilino-4-formyl-pyrimidinforbindelser
BA98296A (bs) Piperazinil-heterociklicna jedinjenja
FI893632A7 (fi) Yhdisteitä
PT90966A (pt) Fechos perfilados
FI891478A7 (fi) Yhdiste
DK594687A (da) Pyrrolidinylthioforbindelser
FI893751A7 (fi) Kemialliset yhdisteet
FI895940A7 (fi) Uusia yhdisteitä
FI890438A7 (fi) Yhdisteet
PT84187A (pt) Novel compounds
DK483689D0 (da) Kemiske forbindelser
PT86766A (pt) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds
FI902602A7 (fi) Uusia yhdisteitä
DK54791A (da) Anti-androgenforbindelser
FI895446A7 (fi) Substituoidut oksadiaminobutaanit
IT1221792B (it) Composti metossimetilici
PT8062Y (pt) Oculos melhorados
FI893924A7 (fi) Yhdisteitä
FI904138A7 (fi) Pyrrolikinoliiniyhdisteet
KR900700506A (ko) Grf 유사 화합물
DK0423802T3 (da) Phenoxyheterocycliske forbindelser

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK